Latest News for: UCB

Edit

UCB Transforms Safety Operations with Veeva Safety Suite in Collaboration with ELIQUENT Life Sciences, Pinnaxis, ...

Canada Newswire 12 Jun 2026
WASHINGTON, June 12, 2026 /CNW/ -- ELIQUENT Life Sciences ("ELIQUENT") today announced the June 1 go-live of Veeva Safety Suite at UCB ... Their teams integrated seamlessly with UCB and Veeva experts to ...
Edit

Reflections from EULAR 2026: advancing early control of inflammation (UCB SA)

Public Technologies 12 Jun 2026
). A moment to reflect and move forward ... Building on the science. At UCB, this focus builds on years of work in immunology and rheumatology ... UCB SA published this content on June 12, 2026, and is solely responsible for the information contained herein.
Edit

UCB Transforms Safety Operations with Veeva Safety Suite in Collaboration with ELIQUENT Life Sciences, Pinnaxis, and Daelight Solutions

PR Newswire 12 Jun 2026
WASHINGTON, June 12, 2026 /PRNewswire/ -- ELIQUENT Life Sciences ("ELIQUENT") today announced the June 1 go-live of Veeva Safety Suite at UCB ... Their teams integrated seamlessly with UCB and Veeva ...
Edit

UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite

PR Newswire 09 Jun 2026
VEEV) today announced that UCB is unifying its global safety operations with Veeva Safety Suite to maximize operational efficiency and scale. UCB is standardizing safety on a single platform to ...
Edit

New EULAR 2026 data show CIMZIA[®] (certolizumab pegol) delivered consistent effect in rheumatoid arthritis, regardless of rheumatoid factor (RF) levels (UCB SA)

Public Technologies 05 Jun 2026
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with ...
Edit

BIMZELX[®](bimekizumab) data at EULAR 2026 show early and sustained inflammation control can improve patient reported outcomes and limit disease progression in PsA and axSpA (UCB SA)

Public Technologies 03 Jun 2026
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with ...
Edit

UCB completes acquisition of Neurona Therapeutics, advancing its leadership as innovator in epilepsy through regenerative science (UCB SA)

Public Technologies 02 Jun 2026
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with ...
Edit

UCB presents research at EUROMIT 2026 highlighting burden of care, need for earlier diagnosis, and impact of pyrimidine nucleoside therapy on people living with TK2d (UCB SA)

Public Technologies 02 Jun 2026
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with ...
Edit

The hidden impact of Thymidine Kinase 2 Deficiency (UCB SA)

Public Technologies 02 Jun 2026
In a recent UCB-led online forum with patients and caregivers, eight out of ten participants reported their first symptoms appeared by that age - typically muscle weakness, unexplained falls, or what was described as 'floppiness' ... UCB.
Edit

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 ...

Nasdaq Globe Newswire 01 Jun 2026
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- UCB�(Euronext Brussels. UCB) and�Biogen Inc.�(Nasdaq.
Edit

Revolutionize Science. Redefine Care. Restore Humanity: One year of progress since the first UCB HS Vision Report (UCB SA)

Public Technologies 01 Jun 2026
One year ago, we shared the first UCB Vision Report, making a clear commitment to the hidradenitis ... Elisa Maggioli, New Product Planning & Research Lead, UCB Redefine Care ... Luis Möckel, Real World Evidence Team Lead, UCB Restore Humanity.
Edit

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus (UCB SA)

Public Technologies 01 Jun 2026
UCB, Brussels, Belgium (www.ucb.com), is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with ...
Edit

UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members

PR Newswire 01 Jun 2026
About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of ...
Edit

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus (Biogen Inc)

Public Technologies 01 Jun 2026
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus ... BRUSSELS, Belgium and CAMBRIDGE, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels ... About UCB.
Edit

Go-Go band UCB: From mom’s basement to Lizzo’s album

Wtop 29 May 2026
WTOP's Jimmy Alexander speaks to Go-Go band UCB about their inclusion in new Lizzo song ... The pop star has sampled UCB’s song “Sexy Lady” for her new album Bitch, which drops on June 5 ... On Father’s Day, UCB will perform a special concert at Nats Park.

Article Search

tools
×
×
×
×